Key result
Lower estimated glucose disposal rate was independently associated with an increased risk of in-stent restenosis (OR 3.393) following percutaneous coronary intervention in patients with NSTE-ACS.
Why the study?
The predictive power of estimated glucose disposal rate (eGDR) for in-stent restenosis (ISR) after PCI in patients with NSTE-ACS remains unclear.
Is estimated glucose disposal rate (eGDR) associated with the risk of in-stent restenosis following PCI in patients with NSTE-ACS?
Observational (n=1,218)
No
Is estimated glucose disposal rate (eGDR) associated with the risk of in-stent restenosis following PCI in patients with NSTE-ACS?
Lower estimated glucose disposal rate (eGDR), a simple marker of insulin resistance, is independently associated with an increased risk of in-stent restenosis following PCI in patients with NSTE-ACS.
Background: Insulin resistance (IR) is closely associated with in-stent restenosis (ISR) following percutaneous coronary intervention (PCI). Nevertheless, the predictive power of the newly developed simple assessment method for IR, estimated glucose disposal rate (eGDR), for ISR after PCI in individuals with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains unclear. Methods: NSTE-ACS cases administered PCI in Beijing Anzhen Hospital between January and December 2015 were enrolled. The included individuals were submitted to at least one coronary angiography within 48 months after discharge. Patients were assigned to 2 groups according to ISR occurrence or absence. eGDR was derived as 21.16 - (0.09 * waist circumference [cm]) - (3.41 * hypertension) - (0.55 * glycated hemoglobin [%]). Multivariate logistic regression analysis and receiver operating characteristic (ROC) curve analysis were performed for evaluating eGDR's association with ISR. Results: Based on eligibility criteria, 1218 patients were included. In multivariate logistic analysis, the odds ratios (ORs) of eGDR as a nominal variate and a continuous variate were 3.393 (confidence interval [CI] 2.099 - 5.488, P < 0.001) and 1.210 (CI 1.063 - 1.378, P = 0.004), respectively. The incremental effect of eGDR on ISR prediction based on traditional cardiovascular risk factors was reflected by ROC curve analysis (AUC: baseline model + eGDR 0.644 vs. baseline model 0.609, P for comparison=0.013), continuous net reclassification improvement (continuous-NRI) of -0.264 (p < 0.001) and integrated discrimination improvement (IDI) of 0.071 (p = 0.065). Conclusion: In NSTE-ACS cases administered PCI, eGDR levels show an independent negative association with increased ISR risk.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) conducted an observational in Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) (n=1,218). Estimated glucose disposal rate (eGDR) vs. Higher eGDR was evaluated on In-stent restenosis (ISR) (OR 3.393, 95% CI 2.099-5.488, p=<0.001). Lower estimated glucose disposal rate was independently associated with an increased risk of in-stent restenosis (OR 3.393) following percutaneous coronary intervention in patients with NSTE-ACS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: